New Psilocybe Species Expands Psychedelic Fungi Catalog

A recent issue of Mushroom Digest reported that scientists had discovered and described a new strain of the psilocybin‑containing mushroom genus Psilocybe, called Psilocybe novae-angliae. This finding expands the known diversity of psychoactive fungi and provides fresh material for studying their biochemical pathways.¹

The species was first isolated in 2015 during fieldwork across diverse habitats. The researchers noted distinctive morphological traits—such as spore print color and cap texture—that set it apart from closely related taxa. By characterizing its genome, they confirmed the presence of genes responsible for psilocybin biosynthesis, underscoring its relevance to both mycological taxonomy and potential therapeutic research.¹

In parallel, a study published by scientists at Stanford University linked sugar breakdown processes to changes in fungal shape and infection capability. Using specific inhibitors, the team halted the fungus’s ability to alter form without affecting other biological functions. These results suggest a targeted antifungal strategy that could spare beneficial soil microorganisms while combating pathogenic strains.²

For mycology practitioners and foragers alike, the discovery of P. novae-angliae highlights how subtle genetic differences can influence not only classification but also ecological roles. Understanding these mechanisms may improve identification protocols, especially where legal or safety concerns intersect with recreational use.

Caveats remain: further studies are needed to confirm the full range of this species’ effects on humans and ecosystems before any practical applications arise. Nonetheless, the addition enriches our knowledge base and sets the stage for future investigations into psilocybin‑producing fungi.¹